Iodophors: Clinical Trials

4 trials of Iodophors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 3 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Recruiting 1
Not applicable1Unknown 1

Follow Iodophors: new trials by email Literature Review of Iodophors trials Research Report on Iodophors

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nasal Antisepsis for C. Auris Prevention
Povidone Iodine Topical - Candida Auris Infection, Colonization, Asymptomatic
Phase 4RecruitingMary K Hayden1202024-01-292025-10-15
Treatment of Calculous Pyonephrosis With 0.5% Iodophors for I-stage PCNL
0.5% Iodophors - Urolithiasis
Not applicableUnknownTongji Hospital932019-08-012019-08-07
Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization
Chlorhexidine gluconate (CHG), Iodophor (10% povidone-iodine) - Hospitalization, Infection
Phase 4CompletedUniversity of California, Irvine139522017-04-032023-12-27
Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions
CHG 2% w/v and IPA 70% v/v, Iodophor 0.7% and IPA 74% w/w - Arthroplasty, Replacement, Hip
Phase 4CompletedJohns Hopkins University202008-08-012013-07-10

Conditions studied

Asymptomatic Infections (1)  ·  Candida auris infection (1)  ·  Infections (1)  ·  Urolithiasis (1)

Sponsors

Johns Hopkins University (1)  ·  Mary K Hayden (1)  ·  Tongji Hospital (1)  ·  University of California, Irvine (1)

Countries

United States (3)  ·  China (1)

Top investigators

James McKinnell, MD (1)  ·  Loren Miller, MD MPH (1)  ·  Mary K. Hayden, MD (1)  ·  Susan Huang, MD MPH (1)  ·  Xinguang Wang, M.A. (1)

Results publications

PMID 37815935, PMID 42315843